News18 » Videos » News18 Shorts

WHO Study Shows Remdesiver Is Ineffective While A Chinese Vaccine Shows Promising Results

Oct 16, 2020 04:16 PM IST iVideos iVideos
Share

According to WHO, Gilead’s Remdesivir had little or no impact on COVID-19 patients’ survival rate or recovery time. The conclusion was drawn after the drug was tested in a clinical trial conducted by the WHO. Meanwhile, a Chinese vaccine has shown promising results BBIBP-CorV, being developed by Beijing, has been touted to be safe & has triggered immune responses in early & mid-stage human trials.

Loading